You just read:

NuSirt Biopharma and OWL Metabolomics Partner to Advance Treatment of NASH / Non-alcoholic Steatohepatitis

News provided by

OWL Metabolomics and NuSirt Biopharma

Sep 20, 2016, 22:00 ET